Polyoxidonium (Azoximer bromide) is intended to treat infectious and inflammatory diseases and pathological conditions caused by impaired immunity.
The main action of Polyoxidonium is based on the influence of the active substance to the protective systems of the body. Polyoxidonium also protects cells from oxidation and other adverse effects.
Polyoxidonium (Azoximer bromide) has a complex action: immunomodulating, detoxifying, antioxidant, moderate anti-inflammatory.
The basis of the mechanism of the Polyoxidonium's immunomodulating is based on a direct action to phagocytic cells and natural killers, as well as stimulation of antibody formation and synthesis of interferon-alpha and interferon-gamma.
Detoxification and antioxidant properties of Polyoxidonium are determined by the structure and high molecular nature of this drug.
Polyoxidonium has a wide range of therapeutic effects. Due to its hypoallergenic properties, the product is considered safe.
Polyoxidonium (Azoximer bromide) is well absorbed in the gastrointestinal tract and is absorbed into the bloodstream, distributed in organs and tissues.
Polyoxidonium normalizes the functions of the immune system and protects the body from infectious threats.
Pharmacological properties of Polyoxidonium are manifested in relation to pathogenic bacteria, viruses and fungi. The active component of Polyoxidonium is included in influenza vaccines.
- treatment and prevention of infectious and inflammatory diseases (viral, bacterial and fungal etiology) that are not amenable to standard therapy both in the acute stage and in the remission stage
- cute and chronic recurrent infectious and inflammatory diseases of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear
- allergic diseases complicated by recurrent bacterial, fungal and viral infections (including hay fever, bronchial asthma)
- prevention of recurrent herpetic infection
- seasonal prophylaxis of exacerbations of chronic foci of infections of the oropharynx, paranasal sinuses, upper respiratory tract, inner and middle ear
prevention of influenza and other acute respiratory infections in the pre-epidemic period
- correction of secondary immunodeficiencies resulting from aging or exposure to adverse factors
- increased individual sensitivity
- pregnancy, the period of breastfeeding
- children under 3 years old
- acute renal failure
- rare hereditary lactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome